Aparna Nathan, PhD
Aparna is a freelance science writer pursuing a PhD in bioinformatics and genomics at Harvard University. She uses her multidisciplinary training to find both the cutting-edge science and the human stories in everything from genetic testing to space expeditions. She was recently a 2021 AAAS Mass Media Fellow at the Philadelphia Inquirer. Her writing has also appeared in Popular Science, PBS NOVA, and The Open Notebook.
Articles by Aparna Nathan, PhD
| 9 min read
Two ongoing Phase 1 trials will produce the first human data on these potentially revolutionary cancer drugs.
| 10 min read
Chemoproteomic tools are yielding early drug candidates for previously undruggable proteins.
| 8 min read
Virus-inspired delivery methods enable gene editing of dysregulated microbes.
| 4 min read
New data show that NK cell engagers may provide a robust alternative to T cell therapies.
| 9 min read
With new tools, researchers hope to improve diagnosis of platelet dysfunction by measuring their forces.
| 9 min read
Drug repurposing trials for ichthyosis reveal complexity in the long-untreated disease.
| 9 min read
A saliva-based test could make it easier to diagnose concussions.
| 10 min read
Customizable hydrogels could make taking diabetes and cancer medications as well as other biologics easier for patients.
| 10 min read
A modular CAR T cell could make cancer therapy safer and more effective.
| 8 min read
A new approach to cell engineering could make off-the-shelf CAR T cell therapies a reality.
| 10+ min read
Slowing female reproductive aging could be the key to improving women’s health.
| 7 min read
A new antibody drug should improve treatment of a rare autoimmune encephalitis.
